Mismatch repair proficiency and in vitro response to 5-fluorouracil

J M Carethers1, D P Chauhan, D Fink

  • 1Department of Medicine, University of California, USA. jcarethers@ucsd.edu

Gastroenterology
|June 26, 1999
PubMed
Abstract

Insights

DNA mismatch repair (MMR) deficiency confers colon cancer cell tolerance to 5-fluorouracil (5-FU). MMR-deficient cells showed enhanced survival, suggesting defective MMR as a resistance mechanism to 5-FU chemotherapy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • The DNA mismatch repair (MMR) system corrects DNA errors, including those from alkylation damage and microsatellite instability.
  • Defects in MMR can lead to tolerance of DNA damage and chemotherapy agents.
  • The role of MMR in response to 5-fluorouracil (5-FU) in colon cancer was investigated.

Purpose of the Study:

  • To investigate the effect of 5-fluorouracil (5-FU) on colon cancer cell lines with varying DNA mismatch repair (MMR) proficiency.
  • To determine if MMR status influences cellular response and tolerance to 5-FU treatment.

Main Methods:

  • Colon cancer cell lines were treated with 5 micromol/L 5-FU.
  • Growth selection was assessed using cell enrichment assays and cloning efficiency.
  • Nucleic 5-FU incorporation and cell cycle progression were analyzed via radiolabeling and flow cytometry.

Main Results:

  • MMR-deficient colon cancer cell lines exhibited a significant growth advantage and enhanced survival when treated with 5-FU.
  • MMR-proficient cells showed a substantial reduction in survival after 10 days of 5-FU exposure.
  • Observed growth differences were not attributable to variations in 5-FU nucleotide uptake or cell cycle arrest.

Conclusions:

  • Intact DNA MMR appears to recognize 5-FU incorporated into DNA, potentially via a distinct mechanism compared to other alkylation damage.
  • Defective DNA MMR may represent a key mechanism contributing to tumor resistance against 5-FU chemotherapy.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Mismatch Repair01:36

Mismatch Repair

Overview
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...